Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RIFM cyclic and non-cyclic terpene alcohol assessment published

This article was originally published in The Rose Sheet

Executive Summary

Research Institute for Fragrance Materials publishes toxicologic and dermatologic assessment on cyclic and non-cyclic terpene alcohols, institute announces in a recent release. Assessment covers 68 materials, including linalool, geraniol and d,l-citronellol, among other high-priority fragrance materials. Group summary and fragrance material reviews show the substances are practically non-irritating, have a low sensitization potential and demonstrate no grounds for environmental concern at current levels of use, RIFM says. Terpene alcohol group summary is written by RIFM's expert panel while the fragrance material reviews are written by RIFM staff. Representing all toxicological data available to RIFM on the ingredients, the assessments are published in the November 2008 issue of Food and Chemical Toxicology. The institute plans to publish group summaries on alcohol branched chain unsaturated, alcohols branch chain saturated, benzaldehyde and its derivatives, and aryl alkyl alcohols. Seven group summaries and 182 fragrance material reviews have already been published; the summaries are used by industry to meet the requirements of the EU's Registration, Evaluation, Authorisation and Restriction of Chemical Substances program
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS016104

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel